Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 50

Sort by

Sort Order Select

Journal Articles

Kinetics of Neoantigen Specific T Cells in Post-Transplant Relapse

Biswas Neupane, Kedwin Ventura, Kevin Quann, Kayla Parr, Sawa Ito

Blood (2023) 142 (Supplement 1): 7040.

https://doi.org/10.1182/blood-2023-172688

Published: 2023

Journal Articles

Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Secondary Central Nervous System Large B-Cell Lymphoma (SCNSL): A Multicenter Retrospective Analysis

Blood (2023) 142 (Supplement 1): 3088.

https://doi.org/10.1182/blood-2023-184345

Published: 2023

Journal Articles

A Necroptosis Inhibitor Functions As a Ferroptosis Inducer in Drug-Resistant Myeloid Malignancies

Kedwin Ventura, Josh Prokopec, Biswas Neupane, Zhenxia Gao, Wei Du, Yinan Gong, Sawa Ito

Blood (2023) 142 (Supplement 1): 413.

https://doi.org/10.1182/blood-2023-173275

Published: 2023

Journal Articles

Safety, Pharmacodynamic, and Anti-Tumor Activity of SL-172154 As Monotherapy and in Combination with Azacitidine (AZA) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Higher-Risk Myelodysplastic Syndromes/Neoplasms (HR-MDS) Patients (pts)

Naval Daver, Anthony Selwyn Stein, Dale Bixby, Wanxing Chai-Ho, Joshua F. Zeidner, Keri Maher, Don A. Stevens, Maximilian Stahl, Karen Yee, Emily K Curran, Sawa Ito, Andrew Sochacki, David A Sallman, Robert Hernandez, Simon Metenou, Bo Ma, Kazunobu Kato, Amer M. Zeidan

Blood (2023) 142 (Supplement 1): 4278.

https://doi.org/10.1182/blood-2023-173991

Published: 2023

Journal Articles

Pilot Trial of IFN-γ and Donor Lymphocyte Infusion to Treat Relapsed AML and MDS after Allogeneic Hematopoietic Stem Cell Transplantation

Sawa Ito, Elizabeth F Krakow, Kedwin Ventura, Amy Rodger, Emily Geramita, Erika Moore, Geoffrey R Hill, Warren D Shlomchik

Blood (2022) 140 (Supplement 1): 7678–7679.

https://doi.org/10.1182/blood-2022-157054

Published: 2022

Journal Articles

A Phase 1/1b Multicenter Ascending Dose Study to Evaluate the Safety of HA-1 Minor Histocompatibility Antigen-Reactive TCR-Modified T Cells (BSB-1001) in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant (alloSCT) for MRD + AML or ALL or Poor/Very Poor Risk MDS

Sawa Ito, Christine Voigt, Constantinos Panousis, Tim Mayall, Mark Shlomchik, Jennifer Roy, Egidio Brocca Cofano, Stephanie Stras, David Apelian, Warren D Shlomchik

Blood (2022) 140 (Supplement 1): 7482–7483.

https://doi.org/10.1182/blood-2022-168949

Published: 2022

Journal Articles

Spontaneous Remission of Secondary Acute Lymphoblastic Leukemia Associated with Lenalidomide Therapy for Multiple Myeloma

Arjun Lakshman, MBBS, Cai Chen, Kayla Parr, Sarah McGregor, Sara Monaghan, MD, Steven H. Swerdlow, MD, Warren D Shlomchik, MD, Mounzer Agha, MD, Sawa Ito, MD PhD

Blood (2019) 134 (Supplement_1): 5200.

https://doi.org/10.1182/blood-2019-129257

Published: 2019

Journal Articles

Very Early Adoptive Transfer of Ex Vivo Generated Multi-Virus Specific T Cells Is a Safe Strategy for Prevention of Viral Infection after Allogeneic T Cell Depleted Stem Cell Transplantation

Pawel Muranski, MD, Sarah I Davies, Sawa Ito, MD, Eleftheria Koklanaris, RN, Jeanine Superata, RN, Quan Yu, Steven L Highfill, PhD, Marianna Sabatino, MD, David F. Stroncek, Minoo Battiwalla, MD, Austin John Barrett

Blood (2018) 132 (Supplement 1): 812.

https://doi.org/10.1182/blood-2018-99-119314

Published: 2018

Journal Articles

Single Cell RNA Sequencing and V(D)J Profiling of T-Cell Large Granular Lymphocytosis

Shouguo Gao, PhD, Zhijie Wu, MD PhD, Carrie Diamond, MD, Bradley Arnold, BS, Valentina Giudice, MD, Lemlem Alemu, BS, John Barrett, MD, Sawa Ito, MD, Sachiko Kajigaya, PhD, Neal S. Young, MD

Blood (2018) 132 (Supplement 1): 2404.

https://doi.org/10.1182/blood-2018-99-115166

Published: 2018

Journal Articles

Neoantigen Landscape of Relapsed Acute Leukemia Following Allogeneic Stem Cell Transplantation

Karolyn Oetjen, MD, Cai Chen, Christian Bradley, BS, Reema Panjwani, BS, Cheng Yan, Minoo Battiwalla, MD, Pawel Muranski, MD, Austin John Barrett, Sawa Ito, MD

Blood (2018) 132 (Supplement 1): 4595.

https://doi.org/10.1182/blood-2018-99-115501

Published: 2018

Journal Articles

PD-1 Is Not a Reliable Marker of Impending Relapse after Allogeneic Stem Cell Transplantation

Prachi Jain, MD, Xin Tian, PhD, Jinguo Chen, MD, Caroline R Cantilena, Christian Bradley, Reema Panjwani, BS, Keyvan Keyvanfar, Fariba Chinian, MS, Eleftheria Koklanaris, RN, Jeanine Superata, RN, Sara Hauffe, RN, Minoo Battiwalla, MD, A John Barrett, MD, Sawa Ito, MD

Blood (2017) 130 (Supplement 1): 4509.

https://doi.org/10.1182/blood.V130.Suppl_1.4509.4509

Published: 2017

Journal Articles

IFN-γ Induces Distinct Single Cell Transcriptomes in Clinical-Grade Mesenchymal Stromal Cells

Reema Panjwani, BS, Stefan Cordes, MD PhD, Zerick Terrell Dunbar, BS, MS, Jinguo Chen, MD, Prachi Jain, MD, Fariba Chinian, MS, Sara Hauffe, RN, Eleftheria Koklanaris, RN, Jeanine Superata, RN, Rongye Shi, MD, Huizhi Zhou, David Stroncek, MD, Nan Zhang, PhD, Sarah Davies, BS, Minoo Battiwalla, MD, Austin John Barrett, MD FRCP, FRCPath, Sawa Ito, MD

Blood (2017) 130 (Supplement 1): 4472.

https://doi.org/10.1182/blood.V130.Suppl_1.4472.4472

Published: 2017

Journal Articles

Safety and Feasibility of Ultra-Low Dose IL-2 As Graft Versus Host Disease Prophylaxis in Haplo-Identical Stem Cell Transplantation- a Proof of Concept Pilot Study

Sawa Ito, MD PhD, Prachi Jain, MD, Caroline R Cantilena, BA, Prathima Anandi, MD, Kit Lu, MD, Fariba Chinian, Debbie Draper, RN, Libby Koklanaris, RN, Sara Hauffe, RN, Jeanine Superata, RN, Andra Krauze, MD, David Stroncek, MD, Adams Sharon, MT, Thomas E. Hughes, PharmD, Pawel Muranski, MD, Minoo Battiwalla, MDMS, John Barrett, MD

Blood (2016) 128 (22): 386.

https://doi.org/10.1182/blood.V128.22.386.386

Published: 2016

Journal Articles

Clofarabine Followed By Lenalidomide for Treatment of High Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia- Preliminary Clinical Outcomes and Potential Immune-Modulating Effects

Prachi Jain, MD, Sawa Ito, MD PhD, Neil Dunavin, MD, Jeffrey K. Klotz, MD, Kit Lu, MD, Eleftheria Koklanaris, RN, BSN, Debbie Draper, RN, BSN, Jeanine Superata, RN, Fariba Chinian, Quan Yu, MS, Keyvan Keyvanfar, BS, Susan Wong, Pawel Muranski, MD, John Barrett, MD, Minoo Battiwalla, MDMS

Blood (2016) 128 (22): 5553.

https://doi.org/10.1182/blood.V128.22.5553.5553

Published: 2016

Journal Articles

Reduced Non Relapse Mortality (NRM) and Survivable Acute Graft Versus Host Disease (GVHD) in the Current Era of Myeloablative Ex Vivo T-Cell Depleted (TCD) Transplantation

Natasha A Jain, MD, Prathima Anandi, MD, Upneet Chawla, BS, MD, Sawa Ito, MD PhD, Debbie Draper, RN, Eleftheria Koklanaris, RN, Sara Hauffe, RN, Jeanine Superata, RN, Robert Q. Le, MD PhD, David Stroncek, MD, Pawel Muranski, MD, Minoo Battiwalla, MD MS, John Barrett, MD

Blood (2016) 128 (22): 4596.

https://doi.org/10.1182/blood.V128.22.4596.4596

Published: 2016

Journal Articles

Early Adoptive Transfer of Ex Vivo Generated Multi-Virus Specific T Cells Is a Safe Strategy to Prevent Viral Reactivation in Recipients of Allogeneic T Cell Depleted Stem Cell Transplant

Pawel Muranski, MD, Greg Whitehill, BS, Debbie Draper, RN, Eleftheria Koklanaris, RN, Jeanine Superata, RN, Quan Yu, MS, Marianna Sabatino, MD, Steven L. Highfill, PhD, Hanh Khuu, MD, Sarah I Davies, Mark Chang, Upneet Chawla, BS, MD, Alexandros Spyridonidis, MD PhD, Gary Fahle, MT,SM, Sawa Ito, MD PhD, David Stroncek, MD, Minoo Battiwalla, MDMS, John Barrett, MD

Blood (2016) 128 (22): 979.

https://doi.org/10.1182/blood.V128.22.979.979

Published: 2016

Journal Articles

Distinct Biomarker Profiles in Ex-Vivo T Cell Depletion Graft Manipulation Strategies: CD34+ Selection Vs CD3/19 Depletion in Matched Sibling Allogeneic Peripheral Blood Stem Cell Transplantation

Caroline R. Cantilena, BA, Sawa Ito, MD PhD, Xin Tian, Prachi Jain, MD, Fariba Chinian, Prathima Anandi, MD, Upneet Chawla, BS, MD, Debbie Draper, RN, Eleftheria Koklanaris, RN, Jeanine Superata, RN, David Stroncek, MD, Pawel Muranski, MD, John Barrett, MD, Minoo Battiwalla, MDMS

Blood (2016) 128 (22): 657.

https://doi.org/10.1182/blood.V128.22.657.657

Published: 2016

Journal Articles

Association of Comprehensive Lipoprotein Profiling with Coronary Artery Disease in Allogeneic Stem Cell Transplant (Allo-SCT) Survivors

Upneet Chawla, BS, MD, Maureen Sampson, MT, Natasha A Jain, MD, Prathima Anandi, MD, Sawa Ito, MD PhD, Eleftheria Koklanaris, RN, Pawel Muranski, MD, John Barrett, MD, Marcus Y Chen, MD, Alan Remaley, MD PhD, Minoo Battiwalla, MDMS

Blood (2016) 128 (22): 828.

https://doi.org/10.1182/blood.V128.22.828.828

Published: 2016

Journal Articles

Activity of the Telomerase Inhibitor GRN163L (Imetelstat) on Acute Myeloblastic Leukemia Blasts Is Enhanced By DNA Methyltransferase Inhibitors Irrespective of TERT Promoter Methylation Status

Caroline R Cantilena, BA, Xin Zhao, MD PhD, Sachiko Kajigaya, PhD, Neil Dunavin, MD, Xin Tian, PhD, Stephen A. Strickland, MD, Bipin N. Savani, MD, Sanjay R. Mohan, MD, Katayoun Rezvani, MDPhD, Xingmin Feng, PhD, Danielle M. Townsley, MD, Minoo Battiwalla, MDMS, Sawa Ito, MD, Austin John Barrett, MDFRCP,FRCPath

Blood (2015) 126 (23): 1267.

https://doi.org/10.1182/blood.V126.23.1267.1267

Published: 2015

Journal Articles

Comparison of Donor KIR Genotype, Recipient CMV Reactivation and Pretransplant MRD in Predicting Relapse after Ex Vivo T-Deplete Allohsct

Robert Q. Le, MD PhD, Prathima Anandi, MD, Xin Tian, PhD, Sawa Ito, MD, Natasha A Jain, MD, Meghali Goswami, Catherine E. Lai, MD, Christopher S. Hourigan, MDPhD, Sharon Adams, Nancy F. Hensel, Austin John Barrett, MDFRCP,FRCPath, Minoo Battiwalla, MD MS

Blood (2015) 126 (23): 3212.

https://doi.org/10.1182/blood.V126.23.3212.3212

Published: 2015

NARROW

Kinetics of Neoantigen Specific T Cells in Post-Transplant Relapse

Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Secondary Central Nervous System Large B-Cell Lymphoma (SCNSL): A Multicenter Retrospective Analysis

A Necroptosis Inhibitor Functions As a Ferroptosis Inducer in Drug-Resistant Myeloid Malignancies

Safety, Pharmacodynamic, and Anti-Tumor Activity of SL-172154 As Monotherapy and in Combination with Azacitidine (AZA) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Higher-Risk Myelodysplastic Syndromes/Neoplasms (HR-MDS) Patients (pts)

Pilot Trial of IFN-γ and Donor Lymphocyte Infusion to Treat Relapsed AML and MDS after Allogeneic Hematopoietic Stem Cell Transplantation

A Phase 1/1b Multicenter Ascending Dose Study to Evaluate the Safety of HA-1 Minor Histocompatibility Antigen-Reactive TCR-Modified T Cells (BSB-1001) in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant (alloSCT) for MRD + AML or ALL or Poor/Very Poor Risk MDS

Spontaneous Remission of Secondary Acute Lymphoblastic Leukemia Associated with Lenalidomide Therapy for Multiple Myeloma

Very Early Adoptive Transfer of Ex Vivo Generated Multi-Virus Specific T Cells Is a Safe Strategy for Prevention of Viral Infection after Allogeneic T Cell Depleted Stem Cell Transplantation

Single Cell RNA Sequencing and V(D)J Profiling of T-Cell Large Granular Lymphocytosis

Neoantigen Landscape of Relapsed Acute Leukemia Following Allogeneic Stem Cell Transplantation

PD-1 Is Not a Reliable Marker of Impending Relapse after Allogeneic Stem Cell Transplantation

IFN-γ Induces Distinct Single Cell Transcriptomes in Clinical-Grade Mesenchymal Stromal Cells

Safety and Feasibility of Ultra-Low Dose IL-2 As Graft Versus Host Disease Prophylaxis in Haplo-Identical Stem Cell Transplantation- a Proof of Concept Pilot Study

Clofarabine Followed By Lenalidomide for Treatment of High Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia- Preliminary Clinical Outcomes and Potential Immune-Modulating Effects

Reduced Non Relapse Mortality (NRM) and Survivable Acute Graft Versus Host Disease (GVHD) in the Current Era of Myeloablative Ex Vivo T-Cell Depleted (TCD) Transplantation

Early Adoptive Transfer of Ex Vivo Generated Multi-Virus Specific T Cells Is a Safe Strategy to Prevent Viral Reactivation in Recipients of Allogeneic T Cell Depleted Stem Cell Transplant

Distinct Biomarker Profiles in Ex-Vivo T Cell Depletion Graft Manipulation Strategies: CD34+ Selection Vs CD3/19 Depletion in Matched Sibling Allogeneic Peripheral Blood Stem Cell Transplantation

Association of Comprehensive Lipoprotein Profiling with Coronary Artery Disease in Allogeneic Stem Cell Transplant (Allo-SCT) Survivors

Activity of the Telomerase Inhibitor GRN163L (Imetelstat) on Acute Myeloblastic Leukemia Blasts Is Enhanced By DNA Methyltransferase Inhibitors Irrespective of TERT Promoter Methylation Status

Comparison of Donor KIR Genotype, Recipient CMV Reactivation and Pretransplant MRD in Predicting Relapse after Ex Vivo T-Deplete Allohsct

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only